Drug data last refreshed 14h ago · AI intelligence enriched 2w ago
CYCLOCORT is a topical ointment small-molecule corticosteroid approved in 1981 for dermatological inflammatory conditions. The drug's mechanism of action involves local immunosuppression and anti-inflammatory activity when applied to affected skin. It treats patients with steroid-responsive dermatological disorders requiring topical corticosteroid therapy.
With LOE approaching and minimal linked job postings, the brand team is likely small and focused on defending market share against generic and branded alternatives in a mature, competitive topical steroid market.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on CYCLOCORT presents a career challenge in a LOE-approaching, mature product with minimal linked job postings, indicating a small, specialized team. Career growth requires focusing on niche expertise in generic defense, customer retention, and topical dermatology market dynamics rather than expansive brand building.
Worked on CYCLOCORT at Astellas? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.